National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 1) (PB 2 of 2021) (Cth)

PB 2 of 2021

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021
(No. 1)

National Health Act 1953

___________________________________________________________________________

I, THEA CONNOLLY, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated    27 January 2021

THEA CONNOLLY

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

___________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2021 (No. 1).

(2)This Instrument may also be cited as PB 2 of 2021.

1. Commencement

This Instrument commences on 1 February 2021.

1. Amendment of National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1       Amendments

1. Schedule 1, after entry for Trihexyphenidyl in the form Tablet containing trihexyphenidyl hydrochloride 2 mg

insert:

Tablet containing trihexyphenidyl hydrochloride 2 mg (USP) 20 200 2